Sanofi (SNY) EBITDA Margin (2009 - 2026)
Sanofi (SNY) posted EBITDA Margin of 16.07% for Q3 2026, up 0.60 percentage points from 15.47% a year earlier.
Sanofi (SNY) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBITDA Margin at Sanofi was 11.18%, down 1.95 percentage points year-over-year; for FY2024, it came in at 20.42%, down 1.06 percentage points from FY2023.
- Annual EBITDA Margin shows a five-year change of +11.28 percentage points (FY2019 to FY2024).
- In prior years, Sanofi's EBITDA Margin was 21.48% in FY2023 (-8.71 pp), 30.19% in FY2022 (+8.47 pp), 21.72% in FY2021 (-17.64 pp) and 39.36% in FY2020 (+30.22 pp).
- The Q3 2026 figure stands as the highest quarterly EBITDA Margin since Q1 2025.
- On a year-over-year basis, EBITDA Margin increased in three of the last four quarters, with an average year-over-year change of +3.65 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2022, with a gain of 23.61 percentage points; the weakest was Q4 2023, with a drop of 36.53 percentage points.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 42.49% |
| 10 | Sanofi | 59.05 Bn | 29.25 Bn | 33.35 Bn | 16.07% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.07% |
| Mar 31, 2026 | 15.09% |
| Sep 30, 2025 | 15.47% |
| Mar 31, 2025 | 26.62% |
| Dec 31, 2024 | 32.93% |
| Mar 31, 2024 | 17.51% |
| Dec 31, 2023 | 16.52% |
| Mar 31, 2023 | 27.71% |
| Dec 31, 2022 | 53.05% |
| Mar 31, 2022 | 28.51% |
| Dec 31, 2021 | 29.45% |
| Mar 31, 2021 | 27.98% |
| Mar 31, 2020 | 26.89% |
| Mar 31, 2019 | 21.14% |
| Dec 31, 2018 | 11.20% |
| Dec 31, 2017 | 24.13% |
| Dec 31, 2016 | 31.93% |
| Dec 31, 2015 | 20.61% |
| Dec 31, 2014 | 34.47% |
| Dec 31, 2013 | 8.22% |
Sanofi EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SNY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();